Physiopathologie des polymyosites et dermatomyosites, mécanismes d'actions des immunoglobulines intraveineusesMOUTHON, L.La Revue de médecine interne (Paris). 2004, Vol 25, pp 10-12, issn 0248-8663, 3 p., HS3Conference Paper

Traitement des érythroblastopénies = Treatment of pure red cell aplasiaCRABOL, Y; MOUTHON, L.La Revue de médecine interne (Paris). 2008, Vol 29, pp 36-43, issn 0248-8663, 8 p., HS1Conference Paper

Traitement des vascularites systémiques ANCA positives par les immunoglobulines intraveineuses = Treatment of ANCA positive vasculitides with intravenous immunoglobulinMOUTHON, L.La Revue de médecine interne (Paris). 1999, Vol 20, pp 431s-435s, issn 0248-8663, SUP4Conference Paper

Papules porcelainées des cuisses = Porcelained papules of the thighDUPIN, N; MOUTHON, L.Images en dermatologie. 2011, Vol 4, Num 4-5, pp 124-126, issn 1964-4167, 3 p.Article

Périartérite noueuse = Polyarteritis noaosaMOUTHON, L; COHEN, P.STV. Sang thrombose vaisseaux. 2000, Vol 12, Num 4, pp 237-241, issn 0999-7385Article

Utilisations thérapeutiques des immunoglobulines intraveineuses = Intravenous immunoglobulines treatmentMOUTHON, L; KAZATCHKINE, M.Concours médical (Paris). 1997, Vol 119, Num 10, pp 693-696, issn 0010-5309Article

Immunité, auto-immunité et vieillissement = Immunity, autoimmunity, ageingMOUTHON, L.La Revue de médecine interne (Paris). 2008, Vol 29, issn 0248-8663, S277-S280, SUP3Conference Paper

Sclérodermie systémique : de la physiopathologie au traitement = Systemic sclerosis : From physiopathology to treatmentMOUTHON, L.La Revue de médecine interne (Paris). 2007, Vol 28, issn 0248-8663, S266-S272, SUP4Conference Paper

Immunoglobulines intraveineuses et maladies systémiques de l'adulte = Intravenous immunoglobulins and adult systemic diseasesHACHULLA, E; CRABOL, Y; MOUTHON, L et al.La Lettre du rhumatologue. 2012, Num 383, pp 22-27, issn 0761-5027, 6 p.Article

Analysis of self-reactive antibody repertoires in normal pregnancyMOUTHON, L; LACROIX-DESMAZES, S; KAZATCHKINE, M. D et al.Journal of autoimmunity (Print). 1998, Vol 11, Num 3, pp 279-286, issn 0896-8411Article

Indications thérapeutiques des immunoglobulines intraveineuses = Intravenous immunoglobulins : therapeutic indicationsMOUTHON, L; BEREZNE, A; LE GUERN, V et al.La Presse médicale (1983). 2005, Vol 34, Num 16, pp 1166-1175, issn 0755-4982, 10 p., CAH1Article

Attitudes thérapeutiques au cours des vascularites = Management of systemic vasculitisTERRIER, B; GUILLEVIN, L; MOUTHON, L et al.Angéiologie (Paris). 2014, Vol 66, Num 2, pp 15-21, issn 0003-3049, 7 p.Article

Les indications thérapeutiques des immunoglobulines intraveineuses = Therapeutic indications of intravenous immunoglobulinsTELLIER, Z; MOUTHON, L.Transfusion clinique et biologique (Paris). 2003, Vol 10, Num 3, pp 179-184, issn 1246-7820, 6 p.Conference Paper

La bronchopneumopathie chronique obstructive: une maladie auto-immune? = Chronic obstructive pulmonary disease: An autoimmune disease?LE GUENNEC, L; PESTRE, V; MOUTHON, L et al.Revue des maladies respiratoires. 2012, Vol 29, Num 4, pp 557-565, issn 0761-8425, 9 p.Article

Association of the CD226 Ser³⁰⁷ Variant With Systemic Sclerosis: Evidence of a Contribution of Costimulation Pathways in Systemic Sclerosis PathogenesisDIEUDE, P; GUEDJ, M; DIOT, E et al.Arthritis and rheumatism. 2011, Vol 63, Num 4, pp 1097-1105, issn 0004-3591, 9 p.Article

Cardiac magnetic resonance imaging in Churg-Strauss-syndrome. Impact of immunosuppressants on outcome assessed in a prospective study on 8 patientsMARMURSZTEJN, J; COHEN, P; DUBOC, D et al.Clinical and experimental rheumatology (Testo stampato). 2010, Vol 28, Num 1, issn 0392-856X, S8-S13, SUP57Article

A descriptive and prognostic study of systemic sclerosis-associated myopathiesRANQUE, B; AUTHIER, F.-J; GHERARDI, R et al.Annals of the rheumatic diseases. 2009, Vol 68, Num 9, pp 1474-1477, issn 0003-4967, 4 p.Article

Association Between the IRF5 rs2004640 Functional Polymorphism and Systemic Sclerosis : A New Perspective for Pulmonary FibrosisDIEUDE, P; GUEDJ, M; CRACOWSKI, J. L et al.Arthritis and rheumatism. 2009, Vol 60, Num 1, pp 225-233, issn 0004-3591, 9 p.Article

Impact of cardiac magnetic resonance imaging for assessment of Churg-Strauss syndrome: a cross-sectional study in 20 patientsMARMURSZTEJN, J; VIGNAUX, O; COHEN, P et al.Clinical and experimental rheumatology (Testo stampato). 2009, Vol 27, Num 1, issn 0392-856X, S70-S76, SUP52Article

Low influenza-vaccination rate among adults receiving immunosuppressive therapy for systemic inflammatory diseaseLANTERNIER, F; HENEGAR, C; MOUTHON, L et al.Annals of the rheumatic diseases. 2008, Vol 67, Num 7, pp 1047-1048, issn 0003-4967, 2 p.Article

Mortality and risk factors of scleroderma renal crisis : a French retrospective study of 50 patientsTEIXEIRA, L; MOUTHON, L; GUILLEVIN, L et al.Annals of the rheumatic diseases. 2008, Vol 67, Num 1, pp 110-116, issn 0003-4967, 7 p.Article

Pneumopathie infiltrante diffuse de la sclérodermie systémique = Interstitial lung disease in systemic sclerosisMOUTHON, L; BEREZNE, A; BRAUNER, M et al.Revue des maladies respiratoires. 2007, Vol 24, Num 8, pp 1035-1046, issn 0761-8425, 12 p.Article

Prevalence of systemic sclerosis in a French multi-ethnic countyLE GUERN, V; MAHR, A; MOUTHON, L et al.Rheumatology (Oxford. Print). 2004, Vol 43, Num 9, pp 1129-1137, issn 1462-0324, 9 p.Article

Lack of association between B19 or V9 erythrovirus infection and ANCA-positive vasculitides: a case-control studyEDEN, A; MAHR, A; SERVANTS, A et al.Rheumatology (Oxford. Print). 2003, Vol 42, Num 5, pp 660-664, issn 1462-0324, 5 p.Article

Prognosis and outcome of 26 patients with systemic necrotizing vasculitis admitted to the intensive care unitCRUZ, B. A; RAMANOELINA, J; MAHR, A et al.Rheumatology (Oxford. Print). 2003, Vol 42, Num 10, pp 1183-1188, issn 1462-0324, 6 p.Article